文献速递认知障碍与谵妄多重用药

社区居住痴呆患者中药物误用与过度使用情况

Medication misuse and overuse in community-dwelling persons with dementia.
PubMed 文献 · J Am Geriatr Soc · 2023-06-05

该研究基于2008至2018年健康与退休研究(HRS)中年龄≥66岁的社区居住成年人,使用经验证的算法识别痴呆患者,并与匹配的无痴呆人群比较。结果显示,73%的痴呆患者被处方至少1种潜在问题药物,其中41%被处方至少1种对认知有负面影响的药物,问题药物使用频率显著高于无痴呆人群。

要点

  • 73%的社区居住痴呆患者被处方至少1种潜在问题药物,人均2.09种。
  • 41%的痴呆患者被处方至少1种对认知有负面影响的药物。
  • 常见问题药物包括PPIs、NSAIDs、阿片类、降压药和降糖药。

核心结论

  • 社区居住痴呆患者频繁接受跨多个领域的问题药物,且频率高于无痴呆人群。
  • 针对痴呆患者的处方精简应不仅关注中枢神经系统活性药物,还应关注PPIs和NSAIDs等其他类别。

研究设计与样本

  • 研究纳入2008至2018年健康与退休研究(HRS)中年龄≥66岁的社区居住成年人,链接Medicare数据,使用经验证的算法分类痴呆。
  • 药物使用情况在HRS访谈日期前1年内确定,并与按年龄、性别、合并症和访谈年份进行倾向性匹配的无痴呆队列比较。
  • 应用调查权重使结果具有全国代表性。

主要发现

  • 在1441名痴呆患者中,中位年龄84岁(四分位距78-89),67%为女性,14%为黑人。
  • 73%的痴呆患者被处方至少1种潜在问题药物,人均2.09种。
  • 41%的痴呆患者被处方至少1种对认知有负面影响的药物。
  • 痴呆患者中问题药物使用高于无痴呆人群:73% vs 67%被处方至少1种问题药物(p=0.002),人均2.09 vs 1.62(p<0.001)。

关键数值与推荐

  • 药物过度使用包括对糖尿病/高血压的过度积极治疗(如胰岛素/磺脲类且血红蛋白A1c < 7.5%)以及基于STOPPFrail的近临终不适当药物。
  • 药物误用包括对认知有负面影响的药物以及来自2019 Beers和STOPP第2版标准的药物。
  • 常见问题药物包括质子泵抑制剂(PPIs)、非甾体抗炎药(NSAIDs)、阿片类、降压药和降糖药。

临床怎么用

  • 针对社区居住痴呆患者的处方精简应不仅关注中枢神经系统活性药物,还应关注PPIs和NSAIDs等其他类别。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Persons with dementia (PWD) have high rates of polypharmacy. While previous studies have examined specific types of problematic medication use in PWD, we sought to characterize a broad spectrum of medication misuse and overuse among community-dwelling PWD. METHODS: We included community-dwelling adults aged ≥66 in the Health and Retirement Study from 2008 to 2018 linked to Medicare and classified as having dementia using a validated algorithm. Medication usage was ascertained over the 1-year prior to an HRS interview date. Potentially problematic medications were identified by: (1) medication overuse including over-aggressive treatment of diabetes/hypertension (e.g., insulin/sulfonylurea with hemoglobin A1c < 7.5%) and medications inappropriate near end of life based on STOPPFrail and (2) medication misuse including medications that negatively affect cognition and medications from 2019 Beers and STOPP Version 2 criteria. To contextualize, we compared medication use to people without dementia through a propensity-matched cohort by age, sex, comorbidities, and interview year. We applied survey weights to make our results nationally representative. RESULTS: Among 1441 PWD, median age was 84 (interquartile range = 78-89), 67% female, and 14% Black. Overall, 73% of PWD were prescribed ≥1 potentially problematic medication with a mean of 2.09 per individual in the prior year. This was notable across several domains, including 41% prescribed ≥1 medication that negatively affects cognition. Frequently problematic medications included proton pump inhibitors (PPIs), non-steroidal anti-inflammatory drugs (NSAIDs), opioids, antihypertensives, and antidiabetic agents. Problematic medication use was higher among PWD compared to those without dementia with 73% versus 67% prescribed ≥1 problematic medication (p = 0.002) and mean of 2.09 versus 1.62 (p < 0.001), respectively. CONCLUSION: Community-dwelling PWD frequently receive problematic medications across multiple domains and at higher frequencies compared to those without dementia. Deprescribing efforts for PWD should focus not only on potentially harmful central nervous system-active medications but also on other classes such as PPIs and NSAIDs.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Deardorff WJ, Jing B, Growdon ME, et al. Medication misuse and overuse in community-dwelling persons with dementia. J Am Geriatr Soc. 2023. PMID: 37272899. doi:10.1111/jgs.18463

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。